Know Cancer

or
forgot password

GIMEMA Guidelines for the Treatment of Adult ALL Affected Patients at Diagnosis


N/A
14 Years
60 Years
Not Enrolling
Both
Leukemia, Lymphocytic, Acute

Thank you

Trial Information

GIMEMA Guidelines for the Treatment of Adult ALL Affected Patients at Diagnosis


Inclusion Criteria:



- Diagnosis of acute lymphoblastic leukemia (ALL)

- Negative myeloperoxidase stain

- Phenotype T (ALL-T) and B(ALL-B)

Exclusion Criteria:

- Creatinine > 2.5mg/dL after adequate hydratation

- LVEF <50%

- Presence of documented infections not responding to antibiotic and/or antifungal
therapy

- Presence of concomitant malignant diseases

- Absence of any psychological condition that does not allow to intake high doses of
cortisone

- Patients who have received any antineoplastic chemiotherapy for more than 5 days

- Patients who have received any steroids for more than 10 days

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Principal Investigator

Franco MANDELLI, Pr

Investigator Role:

Principal Investigator

Investigator Affiliation:

Università degli Studi di Roma "La Sapienza"

Authority:

Italy: The Italian Medicines Agency

Study ID:

LAL2000

NCT ID:

NCT00537550

Start Date:

July 2000

Completion Date:

June 2006

Related Keywords:

  • Leukemia, Lymphocytic, Acute
  • ALL
  • Adult
  • Leukemia
  • Leukemia, Lymphoid
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

Name

Location